Gaps and Solutions
TB diagnostic innovators and other stakeholders identified some of the frequently encountered gaps and challenges along the pathway, along with potential solutions to address them. This is a living resource and we welcome your feedback on these and other issues and/or solutions along the pathway.
Access to Clinical Specimens During Development
Critical for assay developers to validate their assay. The critical steps along the pathway for assay development when specimen banks might be required include: prototype and optimization studies, and validation and verification studies.
Clinician Sensitization
Engagement of medical staff and TB doctors is critical for sustained uptake of new TB diagnostics.
Clinician-focused training – clinical utility of new TB tool
Partner with GLI and NTPs to jointly develop training
Community Engagement
Gather voice of community via focus groups or forums e.g. STBP TB Champion Advocacy Training
Conduct participatory action research (PAR) at every feasible stage – local and global advocacy groups - TB Proof, TAG
Involve TB champions from within community - include in capacity building workshops
Utilize universally designed language in multiple languages
Key organizations: Global advocacy partners e.g. TAG, and local advocacy partners e.g. TB Proof
